|
|
||||||||||
|
J Am Coll Cardiol, 2000; 36:2017-2027 © 2000 by the American College of Cardiology Foundation |
a Thoraxcenter Rotterdam, University Hospital Rotterdam-Dijkzigt, Rotterdam, The Netherlands
Manuscript received January 13, 2000; revised manuscript received June 27, 2000, accepted August 16, 2000.
Reprint requests and correspondence: Marcel L. Geleijnse, MD, Thoraxcenter, Ba 302, Dr Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
ml.geleijnse{at}worldonline.nl
In patients with limited exercise capacity and (relative) contraindications to direct vasodilators such as dipyridamole or adenosine, dobutamine stress nuclear myocardial perfusion imaging (DSMPI) represents an alternative, exercise-independent stress modality for the detection of coronary artery disease (CAD). Nondiagnostic test results (absence of reversible perfusion defects with submaximal stress) do occur in approximately 10% of patients. Serious side effects during DSMPI are rare, with no death, myocardial infarction or ventricular fibrillation reported in three DSMPI safety reports for a total of 2,574 patients. On the basis of a total number of 1,014 patients reported in 20 studies, the sensitivity, specificity and accuracy of the test for the detection of CAD were 88%, 74% and 84%, respectively. Mean sensitivities for one-, two- and three-vessel disease were 84%, 95% and 100%, respectively. The sensitivity for detection of left circumflex CAD (50%) was lower, compared with that for left anterior descending CAD (68%) and right CAD (88%). The sensitivity of predicting multivessel disease by multiregion perfusion abnormalities varied widely, from 44% to 89%, although specificity was excellent in all studies (89% to 94%). In direct diagnostic comparisons, DSMPI was more sensitive, but less specific, than dobutamine stress echocardiography and comparable with direct vasodilator myocardial perfusion imaging. In the largest prognostic study, patients with a normal DSMPI study had an annual hard event rate less than 1%. An ischemic scan pattern provided independent prognostic value, with a direct relationship between the extent and severity of the perfusion defects and prognosis. In conclusion, DSMPI seems a safe and useful nonexercise-dependent stress modality to detect CAD and assess prognosis.
| ||||||||||||||||||||
This article has been cited by other articles:
![]() |
B. J. Krenning, A. Nemes, O. I.I. Soliman, W. B. Vletter, M. M. Voormolen, J. G. Bosch, F. J. ten Cate, J. R.T.C. Roelandt, and M. L. Geleijnse Contrast-enhanced three-dimensional dobutamine stress echocardiography: between Scylla and Charybdis? Eur J Echocardiogr, April 14, 2008; (2008) jen136v1. [Abstract] [Full Text] [PDF] |
||||
![]() |
S C Chua, R H Ganatra, D J Green, and A M Groves Nuclear cardiology: myocardial perfusion imaging with SPECT and PET Imaging, September 1, 2006; 18(3): 166 - 177. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Alsaileek, M. Osranek, K. Fatema, R. B. McCully, T. S. Tsang, and J. B. Seward Predictive Value of Normal Left Atrial Volume in Stress Echocardiography J. Am. Coll. Cardiol., March 7, 2006; 47(5): 1024 - 1028. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Navare, D. Katten, L. L. Johnson, J. F. Mather, M. S. Fowler, A. W. Ahlberg, N. Miele, and G. V. Heller Risk Stratification With Electrocardiographic-Gated Dobutamine Stress Technetium-99m Sestamibi Single-Photon Emission Tomographic Imaging: Value of Heart Rate Response and Assessment of Left Ventricular Function J. Am. Coll. Cardiol., February 21, 2006; 47(4): 781 - 788. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rizzo, M. C. R. Vono, L. Toncelli, P. Pecagna, P. Manetti, L. Stefani, and G. Galanti The feasibility and usefulness of contrast exercise echocardiography for the assessment of left ventricular function in master athletes Eur J Echocardiogr, January 1, 2005; 6(1): 24 - 30. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nasir, R. F. Redberg, M. J. Budoff, E. Hui, W. S. Post, and R. S. Blumenthal Utility of Stress Testing and Coronary Calcification Measurement for Detection of Coronary Artery Disease in Women Arch Intern Med, August 9, 2004; 164(15): 1610 - 1620. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Anagnostopoulos, M Harbinson, A Kelion, K Kundley, C Y Loong, A Notghi, E Reyes, W Tindale, and S R Underwood Procedure guidelines for radionuclide myocardial perfusion imaging Heart, January 1, 2004; 90(90001): i1 - 10. [Full Text] [PDF] |
||||
![]() |
A. F. L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, R. Valkema, J. R. T. C. Roelandt, and D. Poldermans Long-term Prognostic Value of Dobutamine Stress 99mTc-Sestamibi SPECT: Single-Center Experience with 8-year Follow-up Radiology, December 1, 2002; 225(3): 701 - 706. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. F.L. Schinkel, A. Elhendy, R. T. van Domburg, J. J. Bax, E. C. Vourvouri, F. B. Sozzi, R. Valkema, J. R.T.C. Roelandt, and D. Poldermans Prognostic Value of Dobutamine-Atropine Stress Myocardial Perfusion Imaging in Patients With Diabetes Diabetes Care, September 1, 2002; 25(9): 1637 - 1643. [Abstract] [Full Text] [PDF] |
||||
![]() |
ADDITIONAL ARTICLES ABSTRACTED IN ACP JOURNAL CLUB Evid. Based Med., July 1, 2001; 6(4): 99 - 99. [Full Text] [PDF] |
||||
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |